MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2024 International Congress

September 27-October 1, 2024. Philadelphia, PA.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • The Spatiotemporal Characteristics of Floor Sitting Rising in Parkinson’s Disease (PD)

    J. Alomar, D. Wani, T. Yu, S. Leung, L. Romero, S. El-Feky, J. Wong, K. Pu, L. Quinn (New York City, USA)

  • The Spectrum of Presenting Phenotypes in Childhood Onset Huntingtons Disease

    K. Yang, V. Quiroz, A. Tam, X. Villanueva, C. Amarales, D. Ebrahimi-Fakhari (Boston, USA)

  • The study of evaluating the impact of simulating indoor environments using virtual reality on gait in Parkinson’s Disease

    K. Seo, S. Emoto, K. Abe, T. Ishii, M. Miki, M. Hara, T. Yamamoto (Saitama, Japan)

  • The Use of Biometric Feedback Devices for Stratification of Deep Brain Stimulation (DBS) Eligibility and Treatment Response in Parkinson Disease

    E. Kolesnick, H. Ooi, M. Rashid, K. Pain, H. Sarva, A. Deik (New York, USA)

  • The use of modelling in Huntington’s disease

    D. Guest, S. Sathe, C. Sampaio, J. Warner (Princeton, USA)

  • The value of DaT SPECT in rare movement disorders: acquired diseases

    E. Ardila Jurado, L. Zünd-Hofer, F. Brugger, G. Kägi (St. Gallen, Switzerland)

  • The Yips in Golf: Is it a Task-Specific Dystonia ?

    E. van Wensen (Apeldoorn, Netherlands)

  • Therapeutic challenges of long-standing chelator therapy in Wilson’s Disease

    C. Guedes Vaz, H. Pessegueiro, J. Castro Ferreira, J. Gandara, V. Dionísio Lopes, E. Silva, S. Ferreira, C. Pereira, D. Valadares, L. Maia, J. Presa, A. Pinto, A. Costa, C. Rolanda, C. Agostinho, I. Gonçalves, P. Peixoto, R. Costa, S. Lopes, M. Magalhães (Porto, Portugal)

  • Therapeutic effects of PNF techniques versus standard physiotherapy exercise on diaphragmatic muscle activity in in the treatment young onsets of Parkinsons survivors

    T. Karthikeyan (Gurugram, India)

  • Therapeutic restoration of Faecalibacterium prausnitzii in Parkinson’s disease using targeted fructoligosaccharides: a double-blind, placebo-controlled, cross-over trial

    J. O'Sullivan, N. Jayabalan, N. Birch, D. Mondhe, A. Lehn, R. Gordon, R. Adan (Brisbane, Australia)

  • « Previous Page
  • 1
  • …
  • 165
  • 166
  • 167
  • 168
  • 169
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley